Nailfold Capillaroscopic Pattern Changes and Its Correlation with Interstitial Lung Disease (ILD) in Systemic Sclerosis (SSc) Patients.
Launched by ASSIUT UNIVERSITY · Aug 29, 2024
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how changes in the tiny blood vessels near the nails, called nailfold capillaries, can be linked to a condition called interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). Systemic sclerosis is a chronic autoimmune disease that affects the skin and can impact other organs, including the lungs. The researchers want to understand if specific patterns of these blood vessel changes can help identify patients who may be at risk for lung problems.
To participate in this study, you must be an adult with systemic sclerosis, aged between 18 and 90 years old. Unfortunately, individuals with other autoimmune diseases, certain heart conditions, or a history of smoking will not be eligible. If you join the trial, you'll undergo a simple examination to look at the blood vessels in your nails. This study is currently not recruiting participants yet, but it aims to gather important information that could improve understanding and treatment of lung issues in people with systemic sclerosis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult SSc Patients
- Exclusion Criteria:
- • - 1-SSc patients aged less than 18 years old. 2-Individuals with other autoimmune diseases (rheumatoid arthritis, dermatomyositis, connective tissue disease).
- • 3-Congestive heart failure and presence of clubbing. 4-history of smoking. 5-Patients unable to co-operate for nail fold capillaroscopic examination.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported